Protecting Women with Universal Screening
1 in 2 sexually active people will get an STI before age 251,2*
Because 75% of chlamydia infections and nearly 68% of gonorrhea infections in women are asymptomatic, the majority of women with harmful infections never seek screening.3
As a result, nearly 24,000 women become infertile each year because of an untreated STI.4
Risk-based screening = missed opportunities
- ONLY 52% of sexually active women ages 16-24 are screened annually for chlamydia.5
- Risk-based screening assumes full patient disclosure about their sexual history.
- Cases of Chlamydia (CT) and Gonorrhea (NG) are often found even among those who report abstinence.6
- Patients refuse physician-offered screening, due to embarrassment or confidentiality concerns.
An inclusive solution6
A universal screening CT/NG strategy targets women within the high-risk age group covered by guidelines (ages 15-24 years old) regardless of reported sexual activity. This holistic routine approach provides comprehensive benefits to patients, physicians, and healthcare organizations, including:
- Detecting care opportunities that would otherwise be missed.
- Decreasing STI prevalence and infertility issues.
- Reducing total cost of healthcare.